You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer

Authors

  • Xiao-Xiao Peng Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China PubMed articlesGoogle scholar articles
  • Ruoying Yu Translational Medicine Research Institute, Geneseeq Technology Inc, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Xue Wu Translational Medicine Research Institute, Geneseeq Technology Inc, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Shu-Yu Wu Department of Research and Development, Nanjing Geneseeq Technology Inc, Nanjing, China PubMed articlesGoogle scholar articles
  • Can Pi Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China PubMed articlesGoogle scholar articles
  • Zhi-Hong Chen Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China PubMed articlesGoogle scholar articles
  • Xu-Chao Zhang Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China PubMed articlesGoogle scholar articles
  • Cun-Yi Gao Department of Research and Development, Nanjing Geneseeq Technology Inc, Nanjing, China PubMed articlesGoogle scholar articles
  • Yang W Shao Department of Research and Development, Nanjing Geneseeq Technology Inc, Nanjing, China School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Li Liu Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Yi-Long Wu Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China PubMed articlesGoogle scholar articles
  • Qing Zhou Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Qing Zhou; gzzhouqing{at}126.com
View Full Text

Citation

Peng X, Yu R, Wu X, et al
Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer
Journal for ImmunoTherapy of Cancer 2020;8:e000376. doi: 10.1136/jitc-2019-000376

Publication history

  • Accepted December 15, 2019
  • First published January 19, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.